Vascular Endothelial Growth Factor Inhibitor [EPC]

Vascular Endothelial Growth Factor Inhibitor [EPC] was reported 185199 times

Drugs of the Vascular Endothelial Growth Factor Inhibitor [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 POLYPOIDAL CHOROIDAL VASCULOPATHY 244 0.7871
1 RETINAL PIGMENT EPITHELIAL TEAR 505 0.7277
2 BACTERIAL ENDOPHTHALMITIS 178 0.6692
3 NON-INFECTIOUS ENDOPHTHALMITIS 565 0.6655
4 DIABETIC RETINAL OEDEMA 312 0.6142
5 DETACHMENT OF RETINAL PIGMENT EPITHELIUM 517 0.5809
6 SUBRETINAL FIBROSIS 113 0.5795
7 SUBRETINAL FLUID 614 0.5618
8 INTRA-OCULAR INJECTION COMPLICATION 124 0.5463
9 ENDOPHTHALMITIS 3242 0.5399
10 MACULAR SCAR 102 0.5258
11 CHOROIDAL NEOVASCULARISATION 448 0.5221
12 VITRECTOMY 305 0.5117
13 VITREAL CELLS 102 0.5050
14 RETINAL CYST 76 0.4578
15 SUSPECTED TRANSMISSION OF AN INFECTIOUS AGENT VIA PRODUCT 551 0.4426
16 RETINAL SCAR 201 0.4360
17 RETINAL NEOVASCULARISATION 99 0.3929
18 AGE-RELATED MACULAR DEGENERATION 592 0.3897
19 TUMOUR PERFORATION 123 0.3868
20 RETINAL OEDEMA 728 0.3804
21 VITRITIS 700 0.3778
22 NEOVASCULAR AGE-RELATED MACULAR DEGENERATION 506 0.3619
23 VITREOUS OPACITIES 298 0.3527
24 ANTERIOR CHAMBER FLARE 82 0.3519
25 ANTERIOR CHAMBER CELL 248 0.3473
26 VISUAL ACUITY REDUCED TRANSIENTLY 98 0.3182
27 ANTERIOR CHAMBER INFLAMMATION 188 0.3160
28 VITREOUS HAEMORRHAGE 851 0.3077
29 VITREOUS DISORDER 148 0.3064
30 RETINAL OCCLUSIVE VASCULITIS 68 0.3036
31 UROGENITAL FISTULA 70 0.2954
32 RADIATION NECROSIS 156 0.2723
33 COLORECTAL CANCER METASTATIC 643 0.2711
34 RETINOPATHY OF PREMATURITY 150 0.2708
35 GASTROINTESTINAL PERFORATION 1117 0.2684
36 RETINAL DEPIGMENTATION 81 0.2647
37 RETINAL EXUDATES 240 0.2564
38 HYPOPYON 210 0.2536
39 RECTAL PERFORATION 134 0.2486
40 RETINAL VASCULAR DISORDER 144 0.2462
41 HEPATIC ATROPHY 107 0.2388
42 MACULAR HOLE 311 0.2316
43 RETINAL HAEMORRHAGE 1596 0.2238
44 PSEUDOCIRRHOSIS 74 0.2229
45 HYPOTONY OF EYE 93 0.2214
46 KERATIC PRECIPITATES 105 0.2211
47 MACULAR FIBROSIS 149 0.2198
48 RETINAL ISCHAEMIA 133 0.2177
49 ANASTOMOTIC LEAK 146 0.2104
50 RETINAL THICKENING 351 0.2102
51 CATARACT NUCLEAR 139 0.2084
52 METAMORPHOPSIA 377 0.2043
53 OPTICAL COHERENCE TOMOGRAPHY ABNORMAL 174 0.2023
54 GLIOBLASTOMA 336 0.1967
55 POSTERIOR CAPSULE OPACIFICATION 67 0.1953
56 VISUAL ACUITY TESTS ABNORMAL 106 0.1906
57 TUMOUR NECROSIS 197 0.1864
58 PROTEIN URINE 163 0.1801
59 PROTEINURIA 3373 0.1772
60 NASAL SEPTUM PERFORATION 111 0.1716
61 MACULAR OEDEMA 955 0.1702
62 HYPHAEMA 88 0.1686
63 CYSTOID MACULAR OEDEMA 314 0.1665
64 VITREOUS FLOATERS 1629 0.1655
65 BLINDNESS TRANSIENT 1212 0.1642
66 OVARIAN CANCER RECURRENT 262 0.1629
67 BLEEDING VARICOSE VEIN 88 0.1627
68 DRY AGE-RELATED MACULAR DEGENERATION 179 0.1613
69 GLIOMA 100 0.1555
70 INTRAOCULAR PRESSURE DECREASED 80 0.1518
71 EYE HAEMORRHAGE 1991 0.1490
72 EYE INFLAMMATION 1418 0.1485
73 RETINAL DEGENERATION 192 0.1477
74 OESOPHAGEAL VARICES HAEMORRHAGE 310 0.1427
75 OVARIAN CANCER METASTATIC 121 0.1424
76 PERFORATION 114 0.1414
77 SMALL INTESTINAL PERFORATION 264 0.1406
78 OCULAR HYPERTENSION 272 0.1400
79 RETINAL VASCULITIS 164 0.1377
80 TUMOUR RUPTURE 75 0.1335
81 VISUAL ACUITY REDUCED 4422 0.1330
82 RETINAL VEIN OCCLUSION 377 0.1310
83 METASTASES TO PERITONEUM 326 0.1290
84 DUODENAL PERFORATION 126 0.1283
85 TUMOUR HAEMORRHAGE 366 0.1281
86 TOXIC ANTERIOR SEGMENT SYNDROME 139 0.1274
87 ILEAL PERFORATION 84 0.1267
88 EYE LASER SURGERY 74 0.1252
89 RETINAL ARTERY OCCLUSION 314 0.1242
90 COLON CANCER METASTATIC 199 0.1234
91 REVERSIBLE POSTERIOR LEUKOENCEPHALOPATHY SYNDROME 96 0.1228
92 BLINDNESS UNILATERAL 1714 0.1214
93 FEMALE GENITAL TRACT FISTULA 203 0.1188
94 VITREOUS DETACHMENT 257 0.1185
95 ENTEROCUTANEOUS FISTULA 102 0.1156
96 RETINAL VASCULAR OCCLUSION 85 0.1149
97 HEPATOCELLULAR CARCINOMA 824 0.1083
98 SCOTOMA 80 0.1081
99 INTRAOCULAR PRESSURE INCREASED 1371 0.1072
100 IRIDOCYCLITIS 335 0.1059
101 GLIOBLASTOMA MULTIFORME 86 0.1021
102 LARGE INTESTINE PERFORATION 685 0.0985
103 MALIGNANT ASCITES 75 0.0978
104 VARICES OESOPHAGEAL 291 0.0961
105 PROTEIN URINE PRESENT 471 0.0944
106 METASTASES TO MENINGES 212 0.0931
107 WOUND DEHISCENCE 314 0.0928
108 INTESTINAL PERFORATION 1024 0.0911
109 RETINAL DISORDER 235 0.0902
110 RETINAL TEAR 219 0.0887
111 PORTAL HYPERTENSION 273 0.0884
112 CARCINOEMBRYONIC ANTIGEN INCREASED 171 0.0882
113 RETINAL DETACHMENT 807 0.0877
114 PERIPHERAL SENSORY NEUROPATHY 511 0.0873
115 MICROANGIOPATHY 80 0.0851
116 PELVIC ABSCESS 95 0.0827
117 EMBOLISM ARTERIAL 99 0.0824
118 IRITIS 250 0.0822
119 IMMUNE-MEDIATED HEPATITIS 165 0.0807
120 PRODUCT COUNTERFEIT 139 0.0805
121 CORNEAL OEDEMA 180 0.0802
122 SEROUS RETINAL DETACHMENT 67 0.0800
123 ADENOCARCINOMA OF COLON 149 0.0795
124 SUBILEUS 165 0.0792
125 FOREIGN BODY IN EYE 75 0.0782
126 METASTASES TO PLEURA 82 0.0782
127 BLINDNESS 3170 0.0777
128 LYMPHANGIOSIS CARCINOMATOSA 80 0.0768
129 METASTASES TO LUNG 882 0.0763
130 EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED 95 0.0762
131 CORNEAL ABRASION 104 0.0758
132 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 1687 0.0723
133 EMBOLISM 594 0.0715
134 STOMA SITE HAEMORRHAGE 110 0.0714
135 DISEASE PROGRESSION 8232 0.0695
136 EYE OEDEMA 169 0.0688
137 METASTASES TO LIVER 1198 0.0681
138 CARBOHYDRATE ANTIGEN 125 INCREASED 232 0.0680
139 EMBOLISM VENOUS 204 0.0672
140 NEPHROTIC SYNDROME 461 0.0672
141 MALIGNANT PLEURAL EFFUSION 112 0.0664
142 GASTROINTESTINAL TOXICITY 319 0.0663
143 MYELOSUPPRESSION 2312 0.0641
144 UVEITIS 868 0.0639
145 THERAPY PARTIAL RESPONDER 995 0.0637
146 SKIN TOXICITY 360 0.0636
147 CONJUNCTIVAL HAEMORRHAGE 240 0.0628
148 GASTRIC PERFORATION 171 0.0627
149 PORTAL VEIN THROMBOSIS 202 0.0625
150 AMAUROSIS FUGAX 66 0.0613
151 IMMUNE-MEDIATED ADVERSE REACTION 94 0.0612
152 PERIPHERAL MOTOR NEUROPATHY 84 0.0599
153 MUCOSAL INFLAMMATION 1481 0.0565
154 MACULOPATHY 197 0.0555
155 LARGE INTESTINAL OBSTRUCTION 123 0.0550
156 ASCITES 1618 0.0550
157 EYE INFECTION 621 0.0549
158 ACQUIRED GENE MUTATION 71 0.0542
159 CORNEAL DISORDER 118 0.0538
160 IMMUNE-MEDIATED LUNG DISEASE 97 0.0532
161 THROMBOTIC MICROANGIOPATHY 511 0.0524
162 VENOUS THROMBOSIS 202 0.0514
163 HAEMATOTOXICITY 488 0.0513
164 METASTATIC NEOPLASM 221 0.0512
165 DIABETIC RETINOPATHY 173 0.0509
166 BONE MARROW FAILURE 1028 0.0505
167 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 479 0.0501
168 GRANULOCYTE COUNT DECREASED 93 0.0501
169 DERMATITIS ACNEIFORM 304 0.0499
170 METASTASES TO CENTRAL NERVOUS SYSTEM 642 0.0497
171 CEREBRAL ISCHAEMIA 255 0.0495
172 MACULAR DEGENERATION 586 0.0490
173 CATARACT OPERATION 291 0.0490
174 VENA CAVA THROMBOSIS 81 0.0487
175 VENOUS THROMBOSIS LIMB 99 0.0479
176 INTERCEPTED PRODUCT STORAGE ERROR 171 0.0479
177 INTERCEPTED MEDICATION ERROR 221 0.0476
178 GENE MUTATION 94 0.0475
179 FOREIGN BODY SENSATION IN EYES 302 0.0473
180 METASTASES TO LYMPH NODES 319 0.0472
181 PHOTOPSIA 298 0.0471
182 PNEUMOPERITONEUM 87 0.0471
183 EYE INJURY 143 0.0470
184 LUNG ADENOCARCINOMA 141 0.0468
185 METASTASIS 333 0.0466
186 VISUAL FIELD DEFECT 335 0.0463
187 NECROTISING FASCIITIS 163 0.0462
188 DIVERTICULAR PERFORATION 95 0.0461
189 LEUKOENCEPHALOPATHY 171 0.0459
190 NEUROTOXICITY 799 0.0456
191 ILEUS 562 0.0452
192 ACUTE ABDOMEN 66 0.0450
193 NEUTROPHIL COUNT DECREASED 1806 0.0443
194 EYE PAIN 2478 0.0439
195 PARONYCHIA 191 0.0434
196 ARTERIAL THROMBOSIS 84 0.0434
197 POLYNEUROPATHY 516 0.0431
198 MEAN CELL HAEMOGLOBIN INCREASED 71 0.0428
199 NON-SMALL CELL LUNG CANCER 205 0.0428
200 HYPOALBUMINAEMIA 332 0.0427
201 ADENOCARCINOMA 95 0.0424
202 LYMPHADENOPATHY MEDIASTINAL 81 0.0423
203 SMALL INTESTINAL OBSTRUCTION 518 0.0420
204 CHOLANGITIS 258 0.0416
205 PNEUMATOSIS INTESTINALIS 118 0.0413
206 ENTEROCOLITIS 238 0.0412
207 HEPATIC LESION 178 0.0411
208 GASTROINTESTINAL NECROSIS 119 0.0408
209 METASTASES TO BONE 665 0.0405
210 HYDRONEPHROSIS 302 0.0403
211 NEUTROPHIL COUNT ABNORMAL 114 0.0403
212 HYPOPHYSITIS 81 0.0402
213 ULCERATIVE KERATITIS 109 0.0398
214 ENTERITIS 252 0.0393
215 ABDOMINAL ABSCESS 174 0.0393
216 NEOPLASM PROGRESSION 1369 0.0393
217 JUGULAR VEIN THROMBOSIS 70 0.0393
218 METASTASES TO SPINE 129 0.0383
219 IMMUNE-MEDIATED ENTEROCOLITIS 141 0.0383
220 PERIODONTITIS 83 0.0383
221 TUMOUR MARKER INCREASED 183 0.0381
222 REFUSAL OF TREATMENT BY PATIENT 245 0.0375
223 OVARIAN CANCER 344 0.0373
224 HYPERBILIRUBINAEMIA 383 0.0369
225 RECTAL CANCER 110 0.0358
226 HEPATITIS B REACTIVATION 113 0.0356
227 MEAN CELL VOLUME INCREASED 91 0.0354
228 ADRENAL INSUFFICIENCY 430 0.0354
229 NEUROPATHY PERIPHERAL 3328 0.0350
230 PNEUMOTHORAX 554 0.0349
231 VISUAL IMPAIRMENT 4318 0.0348
232 AZOTAEMIA 139 0.0348
233 HYPERTENSIVE CRISIS 387 0.0348
234 SUSPECTED OFF LABEL USE 157 0.0347
235 FEBRILE NEUTROPENIA 2295 0.0346
236 AORTIC DISSECTION 143 0.0345
237 OCULAR DISCOMFORT 386 0.0343
238 RED CELL DISTRIBUTION WIDTH INCREASED 142 0.0341
239 ARTERIOSPASM CORONARY 137 0.0341
240 HEPATIC ENCEPHALOPATHY 318 0.0340
241 THYROIDITIS 102 0.0339
242 ALANINE AMINOTRANSFERASE ABNORMAL 71 0.0336
243 VENOOCCLUSIVE LIVER DISEASE 166 0.0336
244 ANAL FISTULA 178 0.0333
245 EYE DISCHARGE 344 0.0331
246 ABDOMINAL INFECTION 84 0.0329
247 HYPERTENSION 6950 0.0328
248 NEUTROPENIA 4451 0.0327
249 THROMBOCYTOPENIA 3651 0.0326
250 NEOPLASM RECURRENCE 110 0.0324
251 LIVER ABSCESS 105 0.0323
252 CEREBRAL INFARCTION 775 0.0317
253 PERFORMANCE STATUS DECREASED 148 0.0317
254 EYE OPERATION 146 0.0316
255 LEFT VENTRICULAR DYSFUNCTION 211 0.0315
256 FISTULA 353 0.0314
257 HYPERAMMONAEMIA 157 0.0314
258 HYPOPHOSPHATAEMIA 232 0.0314
259 EPISTAXIS 2344 0.0313
260 PRODUCT CONTAMINATION 111 0.0312
261 NEPHRITIS 104 0.0311
262 PROCTITIS 87 0.0310
263 PERITONITIS 641 0.0309
264 LEUKOPENIA 1548 0.0309
265 EXPOSED BONE IN JAW 67 0.0309
266 FEBRILE BONE MARROW APLASIA 131 0.0308
267 URINARY TRACT OBSTRUCTION 73 0.0307
268 ACUTE CORONARY SYNDROME 254 0.0306
269 PULMONARY HAEMORRHAGE 238 0.0304
270 INTESTINAL OBSTRUCTION 1142 0.0303
271 NEUTROPENIC SEPSIS 216 0.0302
272 HAEMOLYTIC URAEMIC SYNDROME 70 0.0302
273 DISSEMINATED INTRAVASCULAR COAGULATION 423 0.0300
274 GLAUCOMA 578 0.0300
275 OPTIC ISCHAEMIC NEUROPATHY 116 0.0299
276 HYPOMAGNESAEMIA 416 0.0298
277 IMMUNE THROMBOCYTOPENIA 136 0.0297
278 SUDDEN DEATH 314 0.0296
279 OESOPHAGITIS 322 0.0294
280 CONJUNCTIVAL HYPERAEMIA 105 0.0294
281 NEOPLASM 338 0.0294
282 WOUND COMPLICATION 100 0.0291
283 HEPATIC FAILURE 878 0.0291
284 DEATH 25058 0.0291
285 PNEUMONITIS 789 0.0289
286 PROCTALGIA 186 0.0289
287 INTERSTITIAL LUNG DISEASE 1399 0.0289
288 EYE DISORDER 936 0.0284
289 HYPOTHYROIDISM 909 0.0284
290 MALIGNANT NEOPLASM PROGRESSION 2908 0.0284
291 LACRIMATION INCREASED 839 0.0277
292 GLOMERULONEPHRITIS 67 0.0273
293 INTENTIONAL PRODUCT USE ISSUE 2391 0.0273
294 STOMATITIS 1651 0.0272
295 MYOCARDITIS 311 0.0271
296 HEPATIC FUNCTION ABNORMAL 1008 0.0270
297 DUODENAL ULCER 189 0.0268
298 BREAST CANCER METASTATIC 286 0.0266
299 CATARACT 1579 0.0265
300 ENCEPHALITIS 181 0.0261
301 INTESTINAL ISCHAEMIA 144 0.0261
302 CHOLECYSTITIS ACUTE 148 0.0261
303 THROMBOTIC THROMBOCYTOPENIC PURPURA 92 0.0261
304 ABNORMAL SENSATION IN EYE 112 0.0260
305 HAEMOPTYSIS 725 0.0260
306 COLITIS ISCHAEMIC 174 0.0258
307 MYOSITIS 231 0.0257
308 AUTOIMMUNE HAEMOLYTIC ANAEMIA 88 0.0256
309 KERATITIS 78 0.0256
310 AORTIC ARTERIOSCLEROSIS 66 0.0256
311 NON-CARDIAC CHEST PAIN 81 0.0256
312 FAILURE TO THRIVE 131 0.0252
313 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 736 0.0251
314 ANAEMIA 4779 0.0250
315 OSTEONECROSIS OF JAW 620 0.0250
316 RECURRENT CANCER 102 0.0250
317 PERIPHERAL ISCHAEMIA 102 0.0250
318 BLOOD BILIRUBIN INCREASED 670 0.0248
319 LYMPHOPENIA 350 0.0247
320 AMYLASE INCREASED 91 0.0246
321 ANAL HAEMORRHAGE 69 0.0246
322 MULTIPLE USE OF SINGLE-USE PRODUCT 138 0.0246
323 CACHEXIA 125 0.0243
324 ATELECTASIS 234 0.0242
325 HEMIPARESIS 410 0.0242
326 ILEUS PARALYTIC 108 0.0242
327 PULMONARY EMBOLISM 2297 0.0241
328 NECROSIS 134 0.0240
329 CARDIOTOXICITY 212 0.0237
330 PLATELET COUNT DECREASED 2532 0.0237
331 BLOOD ALBUMIN DECREASED 187 0.0235
332 ISCHAEMIA 108 0.0235
333 LYMPHOCYTE COUNT DECREASED 409 0.0231
334 DUODENAL ULCER HAEMORRHAGE 66 0.0230
335 HICCUPS 189 0.0230
336 MYOCARDIAL ISCHAEMIA 261 0.0229
337 WOUND INFECTION 249 0.0227
338 PLEURAL EFFUSION 1380 0.0227
339 COLITIS 854 0.0225
340 OCULAR HYPERAEMIA 1068 0.0225
341 LUNG NEOPLASM 96 0.0225
342 ISCHAEMIC STROKE 400 0.0224
343 MYELODYSPLASTIC SYNDROME 322 0.0222
344 PHOTOPHOBIA 418 0.0222
345 DYSAESTHESIA 68 0.0222
346 HEPATIC NEOPLASM 72 0.0220
347 HAEMORRHOIDAL HAEMORRHAGE 107 0.0219
348 HYPOKALAEMIA 1009 0.0218
349 LEFT VENTRICULAR FAILURE 75 0.0218
350 EJECTION FRACTION DECREASED 338 0.0217
351 JAUNDICE CHOLESTATIC 76 0.0215
352 HYPERPYREXIA 91 0.0215
353 THROMBOPHLEBITIS 75 0.0214
354 SHOCK HAEMORRHAGIC 174 0.0214
355 BLEPHARITIS 85 0.0212
356 HYPERTRIGLYCERIDAEMIA 124 0.0212
357 DEEP VEIN THROMBOSIS 1374 0.0211
358 BLOOD PRESSURE DIASTOLIC INCREASED 96 0.0208
359 IMPAIRED HEALING 675 0.0205
360 HEMIPLEGIA 171 0.0205
361 TRANSIENT ISCHAEMIC ATTACK 693 0.0205
362 ANGIOPATHY 115 0.0205
363 OFF LABEL USE 17722 0.0202
364 TUMOUR LYSIS SYNDROME 178 0.0202
365 CONGESTIVE CARDIOMYOPATHY 84 0.0201
366 VISION BLURRED 2753 0.0200
367 SKIN NECROSIS 104 0.0200
368 TYPE 1 DIABETES MELLITUS 120 0.0199
369 GINGIVAL BLEEDING 272 0.0199
370 EXTRAVASATION 81 0.0197
371 SPLENOMEGALY 230 0.0196
372 ACUTE MYELOID LEUKAEMIA 305 0.0196
373 PHLEBITIS 100 0.0195
374 CHOLECYSTITIS 232 0.0195
375 HEPATIC CYST 66 0.0194
376 HAEMOLYTIC ANAEMIA 174 0.0194
377 CARDIAC DYSFUNCTION 72 0.0193
378 CARDIOMYOPATHY 285 0.0193
379 GENERAL PHYSICAL HEALTH DETERIORATION 2231 0.0193
380 ABDOMINAL HERNIA 87 0.0191
381 GUILLAIN-BARRE SYNDROME 92 0.0190
382 SUSPECTED COUNTERFEIT PRODUCT 75 0.0189
383 STRESS CARDIOMYOPATHY 110 0.0189
384 DRUG RESISTANCE 485 0.0189
385 HYPERTHYROIDISM 272 0.0188
386 DEVICE RELATED INFECTION 289 0.0188
387 ASPARTATE AMINOTRANSFERASE INCREASED 995 0.0187
388 FEMORAL NECK FRACTURE 96 0.0187
389 HYPERTRANSAMINASAEMIA 130 0.0187
390 FIBRIN D DIMER INCREASED 66 0.0185
391 MENINGITIS 124 0.0185
392 CYSTITIS HAEMORRHAGIC 74 0.0183
393 NO ADVERSE EVENT 3317 0.0183
394 BONE LESION 66 0.0183
395 ACUTE PULMONARY OEDEMA 102 0.0182
396 HYDROCEPHALUS 99 0.0182
397 CORONARY ARTERY STENOSIS 91 0.0181
398 COLON CANCER 266 0.0178
399 HEPATIC CIRRHOSIS 335 0.0178
400 ERYTHEMA MULTIFORME 166 0.0178
401 CERVIX CARCINOMA 69 0.0176
402 ASTHENOPIA 97 0.0176
403 TRANSAMINASES INCREASED 390 0.0175
404 BRAIN OEDEMA 221 0.0175
405 WHITE BLOOD CELL COUNT DECREASED 1889 0.0174
406 CEREBRAL HAEMORRHAGE 623 0.0174
407 ANAL FISSURE 92 0.0171
408 ODYNOPHAGIA 102 0.0171
409 FAECALOMA 93 0.0170
410 PULMONARY TOXICITY 120 0.0170
411 PYELONEPHRITIS 146 0.0168
412 HYPONATRAEMIA 949 0.0168
413 ANAL ABSCESS 90 0.0167
414 LUNG INFECTION 258 0.0166
415 SECOND PRIMARY MALIGNANCY 138 0.0166
416 ALANINE AMINOTRANSFERASE INCREASED 1018 0.0166
417 BLOOD ALKALINE PHOSPHATASE INCREASED 408 0.0164
418 DEHYDRATION 2189 0.0164
419 LYMPHOEDEMA 113 0.0163
420 DECREASED APPETITE 3793 0.0163
421 HAEMATOCRIT DECREASED 321 0.0162
422 LOWER GASTROINTESTINAL HAEMORRHAGE 119 0.0161
423 SKIN ULCER 416 0.0161
424 HAEMORRHAGE 1680 0.0161
425 HAEMORRHAGIC STROKE 124 0.0159
426 HAEMATURIA 543 0.0158
427 LUNG INFILTRATION 140 0.0158
428 COLITIS MICROSCOPIC 75 0.0158
429 NAIL DISORDER 138 0.0158
430 RECTAL HAEMORRHAGE 675 0.0157
431 HAEMOGLOBIN ABNORMAL 101 0.0157
432 BACTERAEMIA 186 0.0157
433 CYTOPENIA 191 0.0156
434 GINGIVITIS 84 0.0156
435 AUTOIMMUNE HEPATITIS 108 0.0155
436 BLOOD CREATININE INCREASED 1008 0.0154
437 SEPSIS 1711 0.0153
438 PULMONARY MASS 228 0.0153
439 ANEURYSM 76 0.0153
440 KLEBSIELLA INFECTION 77 0.0152
441 SUBARACHNOID HAEMORRHAGE 154 0.0151
442 VENTRICULAR FIBRILLATION 167 0.0150
443 JAUNDICE 404 0.0150
444 HYPOCALCAEMIA 284 0.0150
445 CEREBROVASCULAR ACCIDENT 2523 0.0149
446 SEPTIC SHOCK 647 0.0149
447 CARDIAC FAILURE ACUTE 97 0.0145
448 HYPOVOLAEMIA 85 0.0145
449 ELECTROLYTE IMBALANCE 168 0.0144
450 PATHOLOGICAL FRACTURE 73 0.0144
451 HEPATITIS 367 0.0143
452 MALNUTRITION 160 0.0143
453 FLANK PAIN 134 0.0143
454 RASH PUSTULAR 104 0.0143
455 HAEMATEMESIS 361 0.0142
456 NEPHROPATHY TOXIC 159 0.0142
457 HYPERTHERMIA 108 0.0141
458 MOUTH ULCERATION 298 0.0141
459 HAEMORRHAGE INTRACRANIAL 211 0.0141
460 SUPRAVENTRICULAR TACHYCARDIA 135 0.0141
461 INTERCEPTED PRODUCT ADMINISTRATION ERROR 108 0.0141
462 DYSPHONIA 822 0.0140
463 PIGMENTATION DISORDER 86 0.0139
464 ENCEPHALOPATHY 342 0.0139
465 PANCYTOPENIA 778 0.0139
466 CARDIAC FAILURE 1117 0.0139
467 HEPATOTOXICITY 309 0.0139
468 ABSCESS 221 0.0138
469 ABDOMINAL PAIN 3203 0.0138
470 BLOOD MAGNESIUM DECREASED 118 0.0137
471 INFARCTION 93 0.0136
472 EYE IRRITATION 782 0.0136
473 GASTRIC ULCER 257 0.0135
474 PERICARDIAL EFFUSION 312 0.0135
475 RENAL IMPAIRMENT 1130 0.0134
476 BLOOD LACTATE DEHYDROGENASE INCREASED 212 0.0134
477 UPPER GASTROINTESTINAL HAEMORRHAGE 225 0.0134
478 MELAENA 293 0.0133
479 GASTROENTERITIS 194 0.0133
480 GAMMA-GLUTAMYLTRANSFERASE INCREASED 293 0.0132
481 NO THERAPEUTIC RESPONSE 161 0.0132
482 GASTRIC ULCER HAEMORRHAGE 73 0.0132
483 MUSCULOSKELETAL CHEST PAIN 203 0.0131
484 RHINITIS 105 0.0130
485 THROMBOSIS 1044 0.0130
486 PYREXIA 4484 0.0129
487 BRAIN NEOPLASM 119 0.0129
488 BLOOD PRESSURE INCREASED 1979 0.0129
489 HYPOXIA 454 0.0129
490 RENAL FAILURE CHRONIC 99 0.0129
491 LIVER INJURY 316 0.0129
492 HAEMOGLOBIN DECREASED 1314 0.0128
493 ATRIAL FLUTTER 102 0.0128
494 DIARRHOEA 8238 0.0127
495 MENTAL STATUS CHANGES 354 0.0127
496 NEUTROPHIL COUNT INCREASED 130 0.0127
497 CHOLESTASIS 243 0.0126
498 DECUBITUS ULCER 103 0.0126
499 EYE SWELLING 469 0.0126
500 APHASIA 379 0.0125
501 ORAL DISORDER 92 0.0125
502 RED BLOOD CELL COUNT DECREASED 358 0.0125
503 EOSINOPHIL COUNT INCREASED 104 0.0125
504 DERMATITIS BULLOUS 90 0.0124
505 EYELID PTOSIS 126 0.0124
506 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 93 0.0124
507 HAEMORRHOIDS 241 0.0123
508 BODY TEMPERATURE DECREASED 121 0.0123
509 CIRCULATORY COLLAPSE 209 0.0123
510 ACUTE MYOCARDIAL INFARCTION 361 0.0122
511 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 413 0.0122
512 ATAXIA 145 0.0122
513 BLOOD PRESSURE SYSTOLIC INCREASED 237 0.0121
514 ORAL CANDIDIASIS 160 0.0121
515 UROSEPSIS 112 0.0121
516 LIPASE INCREASED 93 0.0121
517 AORTIC ANEURYSM 92 0.0121
518 NEUROLOGICAL SYMPTOM 69 0.0121
519 MYASTHENIA GRAVIS 97 0.0120
520 RENAL FAILURE ACUTE 509 0.0120
521 HYPERGLYCAEMIA 437 0.0120
522 BLOOD DISORDER 95 0.0118
523 VASCULITIS 138 0.0118
524 RENAL CYST 94 0.0118
525 CONJUNCTIVITIS 219 0.0118
526 HYPERKALAEMIA 412 0.0117
527 OSTEONECROSIS 385 0.0117
528 DISEASE RECURRENCE 557 0.0117
529 ANGINA UNSTABLE 76 0.0117
530 GASTROINTESTINAL HAEMORRHAGE 977 0.0117
531 THYROID DISORDER 180 0.0117
532 VOMITING 5470 0.0116
533 CONSTIPATION 2536 0.0116
534 MULTI-ORGAN FAILURE 201 0.0116
535 SINUS TACHYCARDIA 165 0.0116
536 LIVER DISORDER 513 0.0116
537 ANOREXIA 149 0.0116
538 ACUTE RESPIRATORY DISTRESS SYNDROME 204 0.0115
539 TEMPERATURE INTOLERANCE 119 0.0115
540 BLOOD UREA INCREASED 193 0.0115
541 GASTRIC HAEMORRHAGE 132 0.0115
542 HYPERCALCAEMIA 141 0.0114
543 DEAFNESS 298 0.0114
544 ACUTE HEPATIC FAILURE 155 0.0113
545 GINGIVAL PAIN 90 0.0113
546 BLOOD SODIUM DECREASED 213 0.0113
547 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 116 0.0113
548 ULCER 178 0.0112
549 ANGINA PECTORIS 320 0.0112
550 LEUKOCYTOSIS 202 0.0112
551 SPINAL OSTEOARTHRITIS 98 0.0111
552 NEOPLASM MALIGNANT 744 0.0111
553 ASTHENIA 4176 0.0111
554 PNEUMONIA ASPIRATION 277 0.0111
555 DIARRHOEA HAEMORRHAGIC 103 0.0110
556 RESPIRATORY FAILURE 802 0.0110
557 ILL-DEFINED DISORDER 668 0.0110
558 ARTERIOSCLEROSIS 102 0.0108
559 PNEUMOCYSTIS JIROVECII PNEUMONIA 108 0.0107
560 SKIN HYPERPIGMENTATION 92 0.0107
561 EYE PRURITUS 357 0.0106
562 OEDEMA 576 0.0106
563 DEVICE USE ISSUE 185 0.0106
564 ORAL PAIN 236 0.0105
565 DIPLOPIA 272 0.0105
566 SKIN DISORDER 349 0.0105
567 ESCHERICHIA INFECTION 86 0.0104
568 DERMATITIS 219 0.0104
569 TOOTH EXTRACTION 130 0.0104
570 OCCUPATIONAL EXPOSURE TO PRODUCT 67 0.0104
571 GENERALISED OEDEMA 129 0.0104
572 ANAPHYLACTIC SHOCK 268 0.0104
573 MOUTH HAEMORRHAGE 76 0.0104
574 HEPATIC CYTOLYSIS 132 0.0103
575 TOOTH ABSCESS 105 0.0103
576 LYMPHADENOPATHY 364 0.0103
577 CEREBRAL DISORDER 76 0.0103
578 TROPONIN INCREASED 78 0.0102
579 AGRANULOCYTOSIS 188 0.0101
580 ATRIAL FIBRILLATION 984 0.0101
581 ECCHYMOSIS 69 0.0101
582 EPILEPSY 307 0.0100
583 DYSPNOEA EXERTIONAL 376 0.0100
584 GENERAL PHYSICAL CONDITION ABNORMAL 67 0.0099
585 ALTERED STATE OF CONSCIOUSNESS 214 0.0099
586 POST PROCEDURAL COMPLICATION 189 0.0098
587 INFECTION 1422 0.0098
588 NODULE 128 0.0098
589 RASH MACULO-PAPULAR 217 0.0097
590 INFUSION RELATED REACTION 645 0.0097
591 DRY EYE 484 0.0097
592 GASTRITIS 255 0.0097
593 PULMONARY HYPERTENSION 201 0.0096
594 DIVERTICULITIS 267 0.0096
595 MITRAL VALVE INCOMPETENCE 109 0.0096
596 SPINAL COMPRESSION FRACTURE 79 0.0095
597 BLOOD THYROID STIMULATING HORMONE INCREASED 87 0.0094
598 CONVULSION 540 0.0094
599 TOXIC SKIN ERUPTION 95 0.0094
600 HYPOPHAGIA 241 0.0094
601 RENAL FAILURE 1248 0.0094
602 PROCEDURAL COMPLICATION 72 0.0094
603 FATIGUE 7291 0.0094
604 BODY TEMPERATURE INCREASED 190 0.0093
605 APHTHOUS ULCER 72 0.0093
606 MYOCARDIAL INFARCTION 1617 0.0093
607 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 508 0.0092
608 HEPATOCELLULAR INJURY 131 0.0092
609 INJECTION SITE DISCOMFORT 97 0.0092
610 TENDERNESS 96 0.0092
611 ACUTE RESPIRATORY FAILURE 176 0.0091
612 MULTIPLE ORGAN DYSFUNCTION SYNDROME 259 0.0091
613 BLOOD URINE PRESENT 173 0.0091
614 BRONCHOSPASM 130 0.0091
615 NAUSEA 7196 0.0091
616 C-REACTIVE PROTEIN INCREASED 329 0.0090
617 EMPHYSEMA 91 0.0090
618 PULMONARY THROMBOSIS 98 0.0090
619 INTENTIONAL DOSE OMISSION 255 0.0089
620 TUBULOINTERSTITIAL NEPHRITIS 167 0.0089
621 ASPIRATION 97 0.0088
622 GASTROINTESTINAL DISORDER 793 0.0088
623 APHONIA 123 0.0088
624 BONE DISORDER 160 0.0088
625 INTERCEPTED PRODUCT PREPARATION ERROR 107 0.0087
626 NERVOUS SYSTEM DISORDER 271 0.0087
627 HAEMOLYSIS 67 0.0087
628 APPENDICITIS 81 0.0087
629 SKIN REACTION 122 0.0087
630 ACUTE KIDNEY INJURY 1325 0.0086
631 DRY THROAT 88 0.0086
632 COAGULOPATHY 144 0.0086
633 LUNG DISORDER 422 0.0086
634 HYPERCHOLESTEROLAEMIA 83 0.0086
635 THERAPY NON-RESPONDER 386 0.0086
636 OEDEMA PERIPHERAL 1046 0.0086
637 DRUG ERUPTION 152 0.0086
638 SHOCK 197 0.0086
639 GRAND MAL CONVULSION 79 0.0085
640 URINARY TRACT INFECTION 1448 0.0085
641 PULMONARY OEDEMA 380 0.0085
642 CARDIO-RESPIRATORY ARREST 354 0.0085
643 FRACTURE 160 0.0084
644 GASTROINTESTINAL INFLAMMATION 66 0.0084
645 PANCREATITIS ACUTE 189 0.0084
646 PRODUCT STORAGE ERROR 733 0.0084
647 HYPOACUSIS 360 0.0084
648 TOOTHACHE 151 0.0083
649 BLOOD TEST ABNORMAL 117 0.0083
650 DYSARTHRIA 313 0.0083
651 WEIGHT DECREASED 2313 0.0083
652 NEPHROPATHY 77 0.0082
653 HEPATIC STEATOSIS 153 0.0082
654 FACIAL PARALYSIS 70 0.0082
655 CYTOKINE RELEASE SYNDROME 164 0.0082
656 SYRINGE ISSUE 143 0.0082
657 PANCREATITIS 431 0.0081
658 TACHYCARDIA 723 0.0081
659 PULMONARY FIBROSIS 156 0.0081
660 INFLAMMATION 418 0.0081
661 MUSCULOSKELETAL PAIN 424 0.0081
662 TASTE DISORDER 164 0.0081
663 POST PROCEDURAL HAEMORRHAGE 93 0.0080
664 DYSURIA 294 0.0080
665 RENAL DISORDER 372 0.0080
666 PNEUMONIA 2577 0.0080
667 DYSPHAGIA 755 0.0079
668 BACTERIAL INFECTION 148 0.0079
669 HOSPICE CARE 78 0.0079
670 PETECHIAE 82 0.0079
671 EYELID OEDEMA 91 0.0078
672 PURPURA 69 0.0078
673 RENAL TUBULAR NECROSIS 76 0.0077
674 BLOOD POTASSIUM DECREASED 230 0.0076
675 BLOOD CALCIUM DECREASED 85 0.0076
676 CELLULITIS 380 0.0075
677 HIP FRACTURE 242 0.0075
678 CONFUSIONAL STATE 1216 0.0075
679 SKIN INFECTION 84 0.0075
680 ARRHYTHMIA 354 0.0075
681 RESPIRATORY DISTRESS 206 0.0075
682 SYNCOPE 746 0.0074
683 OSTEOMYELITIS 135 0.0074
684 HYPERLIPIDAEMIA 89 0.0074
685 THROAT TIGHTNESS 200 0.0074
686 MUSCULAR WEAKNESS 840 0.0074
687 ABDOMINAL PAIN LOWER 186 0.0073
688 FACE OEDEMA 124 0.0073
689 DRUG-INDUCED LIVER INJURY 230 0.0073
690 BONE PAIN 429 0.0073
691 BLOOD PRESSURE ABNORMAL 145 0.0073
692 CHILLS 847 0.0072
693 CANDIDA INFECTION 121 0.0072
694 SPEECH DISORDER 375 0.0071
695 MASS 100 0.0071
696 DRUG EFFECT LESS THAN EXPECTED 106 0.0071
697 PARALYSIS 102 0.0071
698 RHINORRHOEA 459 0.0071
699 DYSPNOEA 4006 0.0071
700 CARDIAC ARREST 584 0.0071
701 ALOPECIA 1389 0.0071
702 HAEMATOCHEZIA 386 0.0070
703 INTERNATIONAL NORMALISED RATIO INCREASED 199 0.0070
704 CARDIOMEGALY 85 0.0069
705 HAEMATOMA 179 0.0069
706 DEMENTIA 192 0.0069
707 LUNG NEOPLASM MALIGNANT 281 0.0068
708 ORTHOSTATIC HYPOTENSION 119 0.0068
709 STATUS EPILEPTICUS 77 0.0068
710 OXYGEN SATURATION DECREASED 382 0.0068
711 CHEST PAIN 1256 0.0068
712 DENTAL CARIES 75 0.0068
713 INJURY ASSOCIATED WITH DEVICE 138 0.0068
714 PAIN IN JAW 191 0.0067
715 HYPOAESTHESIA 1009 0.0067
716 HYPOTHERMIA 68 0.0067
717 LIVER FUNCTION TEST ABNORMAL 195 0.0067
718 SKIN FISSURES 131 0.0067
719 NEURALGIA 162 0.0067
720 PRODUCTIVE COUGH 316 0.0066
721 URINARY RETENTION 220 0.0066
722 WOUND 184 0.0066
723 IMMUNODEFICIENCY 98 0.0066
724 RESPIRATORY TRACT INFECTION 170 0.0065
725 HYPOTENSION 1308 0.0065
726 CYSTITIS 207 0.0065
727 SUBDURAL HAEMATOMA 93 0.0065
728 CARDIOVASCULAR DISORDER 164 0.0065
729 SEIZURE 745 0.0064
730 TOOTH INFECTION 85 0.0064
731 CYANOSIS 101 0.0064
732 ANAPHYLACTIC REACTION 354 0.0064
733 HYPERSENSITIVITY 1189 0.0064
734 COUGH 1792 0.0064
735 RIB FRACTURE 131 0.0064
736 STAPHYLOCOCCAL INFECTION 210 0.0064
737 PARAESTHESIA 999 0.0063
738 BACK PAIN 1469 0.0063
739 PHARYNGEAL OEDEMA 97 0.0063
740 IMMUNE SYSTEM DISORDER 83 0.0063
741 LIVER FUNCTION TEST INCREASED 135 0.0063
742 DYSGEUSIA 467 0.0063
743 MALAISE 2730 0.0062
744 DEPRESSED LEVEL OF CONSCIOUSNESS 246 0.0062
745 WHITE BLOOD CELL COUNT INCREASED 238 0.0062
746 CHOLELITHIASIS 203 0.0062
747 PELVIC PAIN 112 0.0062
748 SPINAL PAIN 72 0.0061
749 HERPES ZOSTER 353 0.0061
750 TACHYPNOEA 83 0.0061
751 RASH 2645 0.0061
752 SENSORY DISTURBANCE 97 0.0060
753 CARDIAC FAILURE CONGESTIVE 480 0.0060
754 FEEDING DISORDER 121 0.0060
755 COGNITIVE DISORDER 278 0.0059
756 SCAR 101 0.0059
757 CORONARY ARTERY DISEASE 178 0.0059
758 FALL 1951 0.0059
759 PERICARDITIS 98 0.0058
760 ABDOMINAL DISTENSION 607 0.0058
761 SINUS CONGESTION 78 0.0058
762 THERAPEUTIC RESPONSE DECREASED 350 0.0058
763 DISCOMFORT 347 0.0057
764 CYST 70 0.0056
765 INCORRECT PRODUCT STORAGE 74 0.0056
766 BLOOD PRESSURE FLUCTUATION 135 0.0056
767 DELIRIUM 195 0.0056
768 LETHARGY 322 0.0056
769 UPPER RESPIRATORY TRACT INFECTION 258 0.0056
770 DIABETES MELLITUS 424 0.0056
771 ORAL HERPES 108 0.0055
772 EAR PAIN 106 0.0054
773 PRODUCT PREPARATION ERROR 112 0.0054
774 PLATELET COUNT INCREASED 71 0.0054
775 DISORIENTATION 215 0.0054
776 BLOOD POTASSIUM INCREASED 88 0.0054
777 VERTIGO 329 0.0054
778 DRUG INTOLERANCE 521 0.0054
779 PERIPHERAL COLDNESS 74 0.0054
780 GLOMERULAR FILTRATION RATE DECREASED 66 0.0054
781 BLOOD CREATINE PHOSPHOKINASE INCREASED 154 0.0053
782 CARDIAC DISORDER 498 0.0053
783 LOCALISED INFECTION 128 0.0053
784 UPPER LIMB FRACTURE 105 0.0053
785 PHOTOSENSITIVITY REACTION 87 0.0053
786 UNEVALUABLE EVENT 397 0.0052
787 CENTRAL NERVOUS SYSTEM LESION 72 0.0052
788 URINARY INCONTINENCE 155 0.0052
789 ADVERSE EVENT 480 0.0052
790 TOXICITY TO VARIOUS AGENTS 875 0.0052
791 HEADACHE 3246 0.0052
792 CARDIOGENIC SHOCK 74 0.0052
793 ERYTHEMA 1059 0.0051
794 LABORATORY TEST ABNORMAL 152 0.0051
795 BALANCE DISORDER 443 0.0051
796 ABDOMINAL PAIN UPPER 1055 0.0051
797 PALLOR 139 0.0051
798 BEDRIDDEN 67 0.0051
799 COMA 242 0.0051
800 LOWER RESPIRATORY TRACT INFECTION 231 0.0051
801 VIRAL INFECTION 169 0.0051
802 PRODUCT DOSE OMISSION ISSUE 1490 0.0051
803 MOVEMENT DISORDER 162 0.0050
804 SCIATICA 80 0.0050
805 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 356 0.0050
806 STEVENS-JOHNSON SYNDROME 110 0.0049
807 RESPIRATORY DISORDER 148 0.0049
808 PRODUCT USE ISSUE 926 0.0049
809 CLOSTRIDIUM DIFFICILE INFECTION 106 0.0049
810 PRESYNCOPE 118 0.0048
811 PARAESTHESIA ORAL 70 0.0048
812 OROPHARYNGEAL PAIN 449 0.0048
813 HEART RATE DECREASED 169 0.0048
814 LOCAL SWELLING 83 0.0048
815 DYSPEPSIA 466 0.0047
816 PAIN 2907 0.0047
817 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 246 0.0047
818 MUSCULOSKELETAL DISCOMFORT 81 0.0047
819 FAECES DISCOLOURED 102 0.0047
820 TREATMENT FAILURE 388 0.0047
821 BRADYCARDIA 248 0.0047
822 INTERVERTEBRAL DISC PROTRUSION 102 0.0047
823 TOOTH DISORDER 103 0.0046
824 VENTRICULAR TACHYCARDIA 76 0.0046
825 DIABETIC KETOACIDOSIS 110 0.0046
826 BLOOD COUNT ABNORMAL 69 0.0045
827 HYPOGLYCAEMIA 220 0.0045
828 HEPATIC ENZYME INCREASED 309 0.0045
829 PRODUCT ADMINISTRATION ERROR 91 0.0045
830 SINUS DISORDER 89 0.0045
831 NECK PAIN 251 0.0045
832 GASTROOESOPHAGEAL REFLUX DISEASE 361 0.0045
833 MYALGIA 760 0.0045
834 HALLUCINATION, VISUAL 94 0.0044
835 CHEST DISCOMFORT 455 0.0044
836 THERAPEUTIC PRODUCT EFFECT DECREASED 199 0.0044
837 BRONCHITIS 328 0.0044
838 LOSS OF CONSCIOUSNESS 562 0.0044
839 GAIT DISTURBANCE 824 0.0043
840 NASOPHARYNGITIS 793 0.0043
841 BLOOD PRESSURE DECREASED 285 0.0043
842 LIMB INJURY 116 0.0043
843 OSTEOARTHRITIS 181 0.0043
844 SPINAL FRACTURE 85 0.0042
845 CONTUSION 408 0.0042
846 METABOLIC ACIDOSIS 134 0.0042
847 HERNIA 81 0.0042
848 DIABETES MELLITUS INADEQUATE CONTROL 74 0.0042
849 PRODUCT USE IN UNAPPROVED INDICATION 1033 0.0042
850 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 295 0.0041
851 DRY MOUTH 335 0.0041
852 CONDITION AGGRAVATED 1238 0.0041
853 DRUG INEFFECTIVE 5363 0.0041
854 ARTHRALGIA 1685 0.0040
855 CYTOMEGALOVIRUS INFECTION 67 0.0040
856 FULL BLOOD COUNT DECREASED 81 0.0040
857 HYPERSOMNIA 115 0.0040
858 PAIN IN EXTREMITY 1178 0.0040
859 NIGHT SWEATS 128 0.0040
860 ABASIA 98 0.0040
861 POOR QUALITY SLEEP 85 0.0039
862 FEMUR FRACTURE 122 0.0039
863 EOSINOPHILIA 69 0.0039
864 HEPATIC CANCER 94 0.0039
865 DIZZINESS 1927 0.0039
866 AMNESIA 251 0.0039
867 TINNITUS 177 0.0038
868 SKIN LESION 105 0.0038
869 RETCHING 81 0.0038
870 DRY SKIN 506 0.0038
871 SURGERY 221 0.0038
872 ARTHRITIS 296 0.0038
873 EATING DISORDER 80 0.0038
874 HEART RATE INCREASED 370 0.0037
875 AGEUSIA 92 0.0037
876 TOOTH LOSS 76 0.0037
877 FLUSHING 366 0.0036
878 LIMB DISCOMFORT 111 0.0036
879 FLATULENCE 202 0.0036
880 HEAD INJURY 112 0.0035
881 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 630 0.0035
882 PRODUCT DOSE OMISSION 227 0.0035
883 RASH ERYTHEMATOUS 166 0.0035
884 MUSCLE TWITCHING 79 0.0034
885 SKIN EXFOLIATION 289 0.0034
886 FEELING COLD 95 0.0034
887 HYPERHIDROSIS 431 0.0033
888 CHROMATURIA 75 0.0033
889 FEELING HOT 203 0.0033
890 DEPRESSED MOOD 175 0.0033
891 SKIN DISCOLOURATION 151 0.0033
892 MOBILITY DECREASED 236 0.0033
893 RENAL INJURY 97 0.0033
894 VAGINAL HAEMORRHAGE 141 0.0032
895 FUNGAL INFECTION 108 0.0032
896 GAIT INABILITY 108 0.0032
897 HOSPITALISATION 495 0.0032
898 SWELLING FACE 209 0.0032
899 GLOSSODYNIA 71 0.0032
900 SLEEP DISORDER 222 0.0031
901 SWELLING 294 0.0031
902 NEPHROLITHIASIS 144 0.0031
903 PRURITUS 1206 0.0031
904 ABDOMINAL DISCOMFORT 526 0.0031
905 INFLUENZA 348 0.0031
906 BREAST CANCER 290 0.0031
907 UNRESPONSIVE TO STIMULI 80 0.0031
908 POLLAKIURIA 129 0.0031
909 MENTAL DISORDER 134 0.0031
910 MEMORY IMPAIRMENT 420 0.0031
911 DRUG EFFECT INCOMPLETE 110 0.0030
912 ADVERSE DRUG REACTION 268 0.0030
913 HEART RATE IRREGULAR 67 0.0030
914 MEDICATION ERROR 164 0.0029
915 DEPRESSION 670 0.0029
916 NASAL CONGESTION 173 0.0029
917 BLISTER 165 0.0029
918 ANXIETY 831 0.0029
919 ANGIOEDEMA 129 0.0029
920 INSOMNIA 773 0.0029
921 SINUSITIS 294 0.0029
922 TYPE 2 DIABETES MELLITUS 96 0.0028
923 PALPITATIONS 331 0.0028
924 SOMNOLENCE 569 0.0028
925 INFLUENZA LIKE ILLNESS 232 0.0028
926 ROAD TRAFFIC ACCIDENT 117 0.0028
927 RASH PRURITIC 151 0.0028
928 BLOOD CHOLESTEROL INCREASED 129 0.0028
929 RHABDOMYOLYSIS 115 0.0028
930 RESPIRATORY ARREST 76 0.0028
931 PANCREATIC CARCINOMA 79 0.0027
932 PERIPHERAL SWELLING 419 0.0027
933 CHRONIC KIDNEY DISEASE 206 0.0027
934 RESTLESSNESS 99 0.0027
935 FLUID RETENTION 137 0.0027
936 MUSCLE SPASMS 470 0.0026
937 COVID-19 447 0.0025
938 WHEEZING 151 0.0025
939 ILLNESS 261 0.0025
940 SWOLLEN TONGUE 79 0.0025
941 DYSSTASIA 73 0.0025
942 TREMOR 413 0.0025
943 BLOOD GLUCOSE INCREASED 466 0.0025
944 DRUG ADMINISTRATION ERROR 75 0.0024
945 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 117 0.0024
946 UNDERDOSE 177 0.0024
947 WEIGHT INCREASED 543 0.0024
948 GASTRIC DISORDER 83 0.0024
949 EMOTIONAL DISORDER 74 0.0024
950 COLORECTAL CANCER 113 0.0024
951 PRODUCT QUALITY ISSUE 319 0.0023
952 RASH MACULAR 82 0.0023
953 DRUG INTERACTION 369 0.0023
954 HOT FLUSH 173 0.0023
955 BURNING SENSATION 159 0.0023
956 OSTEOPOROSIS 92 0.0022
957 DRUG EFFECT DECREASED 119 0.0022
958 NERVOUSNESS 114 0.0022
959 THROAT IRRITATION 97 0.0022
960 MIGRAINE 204 0.0021
961 URTICARIA 358 0.0021
962 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 431 0.0021
963 ARTHROPATHY 117 0.0021
964 LIP SWELLING 70 0.0021
965 EXPIRED PRODUCT ADMINISTERED 69 0.0021
966 HALLUCINATION 156 0.0021
967 AGITATION 151 0.0021
968 MUSCULOSKELETAL STIFFNESS 180 0.0021
969 BLOOD GLUCOSE DECREASED 98 0.0020
970 FEELING ABNORMAL 482 0.0020
971 ACNE 152 0.0020
972 INJECTION SITE PAIN 606 0.0020
973 ASTHMA 222 0.0020
974 COLITIS ULCERATIVE 86 0.0019
975 DISTURBANCE IN ATTENTION 102 0.0019
976 INJURY 131 0.0019
977 DRUG DOSE OMISSION 295 0.0018
978 TREATMENT NONCOMPLIANCE 92 0.0017
979 INJECTION SITE HAEMORRHAGE 131 0.0016
980 THERAPY INTERRUPTED 112 0.0016
981 INTENTIONAL PRODUCT MISUSE 134 0.0015
982 DEVICE ISSUE 131 0.0015
983 ECZEMA 76 0.0015
984 JOINT SWELLING 172 0.0014
985 THERAPY CESSATION 73 0.0014
986 ACCIDENTAL EXPOSURE TO PRODUCT 144 0.0014
987 PROSTATE CANCER 109 0.0014
988 EMOTIONAL DISTRESS 125 0.0010
989 INCORRECT DOSE ADMINISTERED 233 0.0010
990 INJECTION SITE REACTION 70 0.0010
991 OVERDOSE 217 0.0010
992 MATERNAL EXPOSURE DURING PREGNANCY 86 0.0010
993 PSORIASIS 100 0.0008
994 RHEUMATOID ARTHRITIS 73 0.0006
995 INJECTION SITE ERYTHEMA 71 0.0006